【摘要】 目的 观察益胃宁胶囊联合瑞巴派特片治疗慢性萎缩性胃炎（CAG）脾胃气虚证的临床疗效。方法 采用随机数字表法将80例CAG患者分为研究组和对照组各40例，2组均予瑞巴派特片，0.1 g/次，每日3次，口服；研究组在此基础上予益胃宁胶囊，2 g/次，每日3次，口服。2组均连续治疗12周。观察2组治疗前后中医疗效、胃镜疗效和病理疗效，比较2组治疗前后中医症状评分，监测2组不良反应。结果 2组均无病例脱落。研究组中医疗效总有效率为92.5%(37/40)，对照组为70.0%(28/40)，研究组中医疗效优于对照组（P<0.01）。与本组治疗前比较，2组治疗后中医症状总分下降（P<0.05,P<0.01）;2组治疗后比较，研究组中医症状总分低于对照组（P<0.01）。研究组胃镜疗效总有效率（82.5%）优于对照组（67.5%），研究组病理疗效总有效率（87.5%）优于对照组（70.0%），差异均有统计学意义（P<0.05,P<0.01）。2组未见明显不良反应。结论 益胃宁胶囊联合瑞巴派特片可有效改善CAG患者的临床症状、胃镜表现及黏膜病变程度，疗效显著。更多还原

【Abstract】 Objective To observe the clinical effects of Yiweining Capsules combined with rebamipide tablet in the treatment of spleen-stomach qi deficiency syndrome in chronic atrophic gastritis(CAG). Methods Totally 80patients with CAG were divided into the study group and the control group by using the random number table method, with 40 cases in each group. Both groups were given rebamipide tablet, 0.1 g/time, 3 times a day, orally; on this basis, the study group added Yiweining Capsules 2 g/time, 3 times a day, orally. Both groups were treated continuously for 12 weeks. The TCM efficacy, the efficacy of gastroscopy and the efficacy of histopathology in the two groups were observed. The TCM symptom score before and after treatment in two groups were observed. The adverse reactions were recorded. Results No cases fell off in both groups. The total effective rate was 92.5%(37/40)in the study group and 70.0%(28/40) in the control group, and the clinical efficacy of the study group was better than that of the control group(P<0.01). Compared with before treatment, the total TCM symptom scores in the two groups after treatment decreased(P<0.01); Compared with after treatment, the total scores of TCM symptom in the study group were lower than those in the control group(P<0.05, P<0.01). The total effective rate of gastroscopy in the study group(82.5%) was better than that in the control group(67.5%), with statistical significance(P<0.05). The overall efficacy rate of histopathdogy in the study group(87.5%) was better than that of the control group(70.0%),with statistical significance(P<0.01). There were no adverse reactions in both groups. Conclusion Yiweining Capsules combined with rebamipide tablet can effectively improve the clinical symptoms, gastroscopic manifestations and the degree of mucosal lesions in patients with CAG, with remarkable efficacy.更多还原